Aarti Drugs gains as PAT rises to Rs 37 cr in Q3; declares dividend of Re 1/sh
Aarti Drugs advanced 2.11% to Rs 405.80 after the pharmaceutical company's consolidated net profit rose 1.04% to Rs 37.05 crore in Q3 FY25, compared with Rs 36.67 crore recorded in Q3 FY24.
How can Budget 2025 make the consumer retail sector get back on its growth trajectory
Budget expectations in consumer retail sector include higher income tax exemptions, GST reductions on essential items and ...
CAMS shares dip over 5% despite robust Q3 FY25 Earnings
CAMS stock falls despite 40.5% profit surge in Q3 FY25, with revenue and EBITDA also showing significant growth.
Tata Motors had accounting, PLI save the day in Q3, leaving investors unimpressed
Investors await key catalysts such as the first electric Jaguar car that is likely to be produced in late 2025 and/or the implementation of the proposed split into two separate entities into CV and PV ...
Fertiliser stocks see pre-Budget bump; RCF, Madras Fertiliser, Coromandel surge 2-3%
Market experts anticipate that the Finance Minister will allocate Rs 1.7 lakh crore towards fertiliser subsidies ...
Tata Motors expects gradual improvement in domestic demand
Tata Motors is expecting a gradual improvement in terms of demand in the fourth quarter of FY25, a top official said on ...
Stocks to buy before budget 2025: Hero MotoCorp to Dabur India — experts recommend five shares on income tax relief buzz
Experts recommend five shares to buy today on income tax relief buzz for the Indian middle class — Hero MotoCorp, Dabur India ...